Nivatrotamab | m-entrepreneurship.com

Product Name :
Nivatrotamab

Search keywords :
3F8

drugId :
null

Target Vo:
Disialoganglioside GD2

Target Vo Short Name :
GD2

Moa_Name:
Disialoganglioside GD2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Memorial Sloan Kettering Cancer Center

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Osteosarcoma

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Retinoid X Receptor alpha Antibody
eIF4A1 Antibody (YA774)
Bcl-XL Antibody: Bcl-XL Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to Bcl-XL. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts